Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity

Annals of Pharmacotherapy

Volumn 37, Issue 10, 2003, Pages 1497-1501

  West, Patricia M ^a   Fernández, Cristina ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Aspirin; Asthma; COX 2 inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

ASTHMA; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; ENZYME INHIBITION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; CYCLOOXYGENASE 2; DRUG HYPERSENSITIVITY; HUMANS; ISOENZYMES; LACTONES; MEMBRANE PROTEINS; META-ANALYSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; SULFONAMIDES; SULFONES;

EID: 0141781233     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C497     Document Type: Review

References (14)

1. Szczeklik A, Nizankowska E, Mastalerz L, Szabo Z. Analgesics and asthma. Am J Ther 2002;9:233-43.
2. Namazy JA, Simon RA. Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002;89:542-50.
3. Szczeklik A, Niz Ankowska E. Clinical features and diagnosis of aspirin induced asthma. Thorax 2000;55(suppl 2):S42-4.
4. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. NSAID hypersensitivity in the COX-2 inhibitor era. ACI Int 2001;13:211-8.
5. Babu KS, Salvi SS. Aspirin and asthma. Chest 2000;118:1470-6.
6. Bochnenek G, Niz Ankowska E, Szczeklik A. Testing for aspirin hypersensitivity. Allergy 2002;57:562-5.
7. Szczeklik A, Niz Ankowska E, Sanak M, Swierczynska M. Aspirin-induced rhinitis and asthma. Curr Opin Allergy Clin Immunol 2001;1:27-33.
8. Niz Ankowska E, Szczeklik A. Glucocorticosteroids attenuate aspirin-precipitated adverse reactions in aspirin-intolerant patients with asthma. Ann Allergy 1989;63:159-62.
9. Pauls JD, Simon RA, Daffern PJ, Stevenson DD. Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol 2000;85:40-5.
10. Stevenson DD, Simon RA, Mathison DA, Christiansen SC. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol 2000;85:477-82.
11. Szczeklik A, Niz Ankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31:219-25.
12. Martin-Garcia C, Hinojosa M, Berges P, Camacho E, Garcia-Rodriguez R, Alfaya T, et al. Safety of cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest 2002;121:1812-7.
13. Woessner KM, Simon RA, Stevenson DD. The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002;46:2201-6.
14. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.